To assess the feasibility of real-time MRI temperature monitoring and ablation zone assessment during RFA of LAPC.
ID
Source
Brief title
Condition
- Gastrointestinal neoplasms malignant and unspecified
- Gastrointestinal therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Primary outcome is to assess the feasibility of real-time MRI temperature
monitoring during RFA of locally irresectable pancreatic cancer.
Secondary outcome
Secondary outcomes are assessment of correlation of per-procedural MRI-guided
delineated zone of ablation with ablation effect on CT scan day 7 after RFA and
verification on intraoperative MRI of the localization, distance to adjacent
structures and position within the tumour of the ultrasound guidance placed
needles.
Background summary
In the PELICAN-trial the benefit of intraoperative local radiofrequency
ablation (RFA) therapy of irresectable locally advanced pancreatic cancer
(LAPC) is investigated in a randomized multicenter phase III clinical trial.
Intraoperative RFA of LAPC has been shown to be feasible and safe, but
temperature feedback during the ablation procedure is currently lacking.
Therefore, the extent of ablation has to be estimated based on modeling and
phantom studies and intraoperative assessment of treatment efficacy and
complication risks is limited. Intraoperative MR imaging of RFA therapy could
provide MRI temperature feedback allowing real-time monitoring of the ablation
process and enable delineation of the true ablation zone following RFA therapy.
Study objective
To assess the feasibility of real-time MRI temperature monitoring and ablation
zone assessment during RFA of LAPC.
Study design
Prospective, non-randomized, single centre pilot study.
Study burden and risks
Patients will undergo intraoperative MR imaging while under general anaesthesia
for the exploratory laparoscopy procedure performed within the PELICAN-trial.
The addition of intraoperative MR imaging is therefore expected to place no
direct increased burden on the patients. However, total procedure time and
anaesthesia time may be longer due to transfer of the patient to and from the
MRI suite, which is anticipated at approximately 30 minutes. Most important
risk of the study would be unwanted attraction of metallic objects to the
magnet, which may be introduced to the MRI environment upon patient transfer.
Such an event would pose hazard to the patient and/or clinical staff members
present in the MRI room. To ensure proper management of these risks, an MRI
safety protocol was established. A safety checklist will be used during all
procedures to ensure all safety measures have been taken correctly before
patient transfer is commenced. Also, one staff member will be charged with
ensuring and safeguarding the safe working environment within the MR scan room
and is required to be present during all procedures. With these safety
measures, no additional risk to the patient or operating team is expected. Most
important potential benefits of intraoperative MR imaging during the RFA
therapy are that per-procedural complications may be avoided by monitoring of
temperatures near adjacent structures-at-risk as well as the ability to
visualize the zone of effective treatment, which may hold predictive value for
therapy response and patient prognosis.
Geert Grooteplein Zuid 10
Nijmegen 6525GA
NL
Geert Grooteplein Zuid 10
Nijmegen 6525GA
NL
Listed location countries
Age
Inclusion criteria
Participation in PELICAN-trial and randomized for RFA-treatment
Exclusion criteria
Contra-indications to undergo MR imaging
Impossibility to obtain informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL59767.018.17 |